Best Practice Guide: Continuous subcutaneous insulin infusion (CSII) A clinical guide for adult diabetes services
This document aims to provide healthcare professionals with UK expert consensus on the best practice for managing and optimising CSII.
This document aims to provide healthcare professionals with UK expert consensus on the best practice for managing and optimising CSII.
Privacy Policy | Website Terms and Conditions
Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS
Telephone: 01675 477602 Email: info@abcd.care
ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd
ABCD Corporate Pharma Sponsors; Gold: Boehringer Ingelheim & Eli Lilly & Co Alliance, Lilly, Novo Nordisk Ltd
ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, Insulet International Ltd; Silver: Medtronic Ltd, Medtrum Ltd; Bronze: Air Liquide Healthcare Ltd, CamDiab, Roche Diabetes Care.